All patients were routinely examined for tumor markers, including carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and carbohydrate antigen 72-4 (CA72-4). This evidence concerns the gene CEACAM5 and neoplasm.